Effect of Increased Light Exposure on Fatigue in Breast Cancer

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-11-30

Study Completion Date

2009-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients treated with chemotherapy complain of poor sleep, fatigue and depression. In addition, chemotherapy disrupts the body's internal "biological clock", which may make sleep, fatigue and depression all worse. Women with breast cancer undergoing chemotherapy are not exposed to much bright light and this may also contribute to the disruption of their body clock, because bright light is necessary for a strong biological clock. One of the easiest ways to strengthen the biological clock is by increasing bright light exposure. The correct timing of the light exposure will help the women feel more alert during the day.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prophylactic Treatment of Sleep/Fatigue Before and During Chemotherapy

NCT01542983

Stage, Breast Cancer

WITHDRAWN NA

Bright Light on Fatigue in Women Being Treated for Breast Cancer

NCT02658708

Breast Neoplasms Breast Cancer Cancer of Breast +1 more

COMPLETED PHASE1

Systematic Light Exposure for Fatigue in Breast Cancer Patients

NCT03217201

COMPLETED NA

Treating Cancer-Related Fatigue Through Systematic Light Exposure

NCT01873794

Hematopoietic Stem Cell Transplantation Breast Cancer Fatigue +4 more

COMPLETED NA

The Effects of Light Therapy to Treat Cancer-related Side Effects

NCT04418856

Breast Cancer Circadian Rhythms Fatigue +4 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients treated with chemotherapy complain of poor sleep, fatigue and depression. Our preliminary research suggests that these symptoms may all be related, that chemotherapy disrupts circadian rhythms which may exacerbate the poor sleep and fatigue and that during chemotherapy, women are not exposed to much bright light which likely also contributes to the disruption of rhythms. One of the easiest circadian rhythms to measure is sleep/wake activity and the easiest way to synchronize this rhythm is with bright light treatment. It is well established that bright light exposure will make rhythms more robust, and the correct timing of the light exposure will have an alerting effect.

We hypothesize that after bright light treatment compared to dim light treatment during three cycles of chemotherapy: fatigue (measured by the Multidimensional Fatigue Symptom Inventory), depression (measured by the Center of Epidemiological Studies-Depression scale), functional outcome scores (measured by the Functional Outcome of Sleep Questionnaire and by the Functional Assessment of Cancer Therapy-Breast), and sleep measures (measured by actigraphy, e.g., total sleep time, total wake time, bouts of sleep, napping) will all be improved. We also hypothesize that circadian rhythms (measured by actigraphy) will be more robust and more synchronized.

The aims are to examine the effect of bright light treatment on subjective measures of fatigue, mood and functional outcome experienced during chemotherapy, to examine the effect of bright light treatment on the quality and quantity of sleep during chemotherapy, to examine the effect of bright light treatment on sleep/wake rhythms during chemotherapy. Women with breast cancer stages I-III scheduled to begin chemotherapy will be recruited. Wrist actigraphy data (for the measurement of sleep/wake activity) will be collected for three consecutive days and nights immediately preceding chemotherapy and questionnaire data (fatigue, mood, quality of life, functional outcome, sleep) will be collected during this same time period. Half the women will be randomized to receive bright light and the other half to dim red light as a control. Daily bright light or dim light treatment will be administered during cycles 2, 3 and 4 of chemotherapy and all measures (actigraphy and questionnaires) will be repeated during the first and last weeks of cycle 1 and cycle 4 chemotherapy. If bright light can improve sleep rhythms and fatigue, then the quality of life of these women is likely to improve.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 Active Bright White Light Treatment

Intervention: Bright white light, the intervention, was administered via a light box made by Litebook Inc for 30 minutes each morning during four cycles of chemotherapy

Group Type ACTIVE_COMPARATOR

bright white light

Intervention Type DEVICE

Intervention: Bright white light administered for 30 minutes each morning

2 Comparator Red Light Treatment

Intervention: Dim red light, the intervention, was administered via a light box made by Litebook Inc for 30 minutes each morning during four cycles of chemotherapy

Group Type ACTIVE_COMPARATOR

comparator red light treatment

Intervention Type DEVICE

dim red light administered for 30 minutes every morning

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bright white light

Intervention: Bright white light administered for 30 minutes each morning

Intervention Type DEVICE

comparator red light treatment

dim red light administered for 30 minutes every morning

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* stage I-III breast cancer
* adjuvant or neoadjuvant anthracycline-based chemotherapy

Exclusion Criteria

* under age 18
* pregnancy
* metastatic or inoperable (including inflammatory) breast cancer
* confounding underlying medical illnesses
* history of mania
* history of other axis-I psychiatric disorder
* other physical or psychological impairments -

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No